Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: A phase I study

被引：0
|
作者：
Siegel, D. S. [1 ,2 ,3 ,4 ,5 ,6 ]
Weber, D. M. [1 ,2 ,3 ,4 ,5 ,6 ]
Mitsiades, C. S. [1 ,2 ,3 ,4 ,5 ,6 ]
Dimopoulos, M. A. [1 ,2 ,3 ,4 ,5 ,6 ]
Harousseau, J. L. [1 ,2 ,3 ,4 ,5 ,6 ]
Rizvi, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Howe, J. [1 ,2 ,3 ,4 ,5 ,6 ]
Reiser, D. [1 ,2 ,3 ,4 ,5 ,6 ]
Anderson, K. C. [1 ,2 ,3 ,4 ,5 ,6 ]
Richardson, P. G. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[2] MD Anderson Canc Ctr, Houston, TX USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Univ Athens, Sch Med, GR-11527 Athens, Greece
[5] Ctr Rene Gauducheau, Saint Herblain, France
[6] Merck & Co Inc, Upper Gwynedd, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8586
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma
    Haruhito Totani
    Masaki Ri
    Chie Kato
    Takahiro Nakashima
    Nana Suzuki
    Shinya Hagiwara
    Takashi Kanamori
    Satsuki Murakami
    Arisa Masuda
    Shiori Kinoshita
    Takashi Yoshida
    Tomoko Narita
    Asahi Ito
    Shigeru Kusumoto
    Takashi Ishida
    Hirokazu Komatsu
    Shinsuke Iida
    International Journal of Hematology, 2016, 103 : 316 - 321
  • [22] Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma
    Totani, Haruhito
    Ri, Masaki
    Kato, Chie
    Nakashima, Takahiro
    Suzuki, Nana
    Hagiwara, Shinya
    Kanamori, Takashi
    Murakami, Satsuki
    Masuda, Arisa
    Kinoshita, Shiori
    Yoshida, Takashi
    Narita, Tomoko
    Ito, Asahi
    Kusumoto, Shigeru
    Ishida, Takashi
    Komatsu, Hirokazu
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (03) : 316 - 321
  • [23] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
    Palumbo, Antonio
    Dimopoulos, Meletios
    San Miguel, Jesus
    Harousseau, Jean-Luc
    Attal, Michel
    Hussein, Mohamad
    Knop, Stefan
    Ludwig, Heinz
    von Lilienfeld-Toal, Marie
    Sonneveld, Pieter
    BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
  • [24] A Phase I Study of Bendamustine Combined with Lenalidomide and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma.
    Lentzsch, Suzanne
    O'Sullivan, Amy
    Lalo, Silvana
    Kruppa, Carrie
    Gardner, Diane
    Kennedy, Ryan C.
    Burt, Steve
    Mapara, Markus Y.
    Redner, Robert
    Roodman, David
    Volkin, Robert L.
    Zonder, Jeffrey
    BLOOD, 2009, 114 (22) : 736 - 736
  • [25] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (vol 4, e182, 2014)
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    BLOOD CANCER JOURNAL, 2014, 4 : e202 - e202
  • [26] Vorinostat Overcomes Lenalidomide-Dexamethasone and Lenalidomide-Bortezomib-Dexamethasone Resistance In Relapsed/Refractory Multiple Myeloma
    Siegel, David Samuel DiCapua
    McBride, Laura
    Bilotti, Elizabeth
    Schmidt, Linda
    Gao, Zhijie
    Tufail, Madiha
    Lendvai, Nikoletta
    McNeill, Ann
    Donadio, Kristen
    Olivo, Karly
    Bednarz, Urzula
    Graef, Thorsten
    Vesole, David H.
    BLOOD, 2010, 116 (21) : 1264 - 1264
  • [27] Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study
    Jakubowiak, Andrzej J.
    Richardson, Paul G.
    Zimmerman, Todd
    Alsina, Melissa
    Kaufman, Jonathan L.
    Kandarpa, Malathi
    Kraftson, Stephanie
    Ross, Charles W.
    Harvey, Colleen
    Hideshima, Teru
    Sportelli, Peter
    Poradosu, Enrique
    Gardner, Lesa
    Giusti, Kathy
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (04) : 472 - 480
  • [28] A Phase I Study of Ixazomib in Combination with Panobinostat and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
    Reu, Frederic J.
    Valent, Jason
    Malek, Ehsan
    Sobecks, Ronald M.
    Faiman, Beth M.
    Hamilton, Kimberly
    Elberson, Jamie
    Fada, Sherry
    Liu, Hien K.
    Samaras, Christy
    Smith, Mitchell R.
    BLOOD, 2015, 126 (23)
  • [29] Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
    Victoria Mateos, Maria
    Prosper, Felipe
    Martin Sanchez, Jesus
    Ocio, Enrique M.
    Oriol, Albert
    Motllo, Cristina
    Michot, Jean-Marie
    Jarque, Isidro
    Iglesias, Rebeca
    Sole, Maria
    Martinez, Sara
    Kahatt, Carmen
    Fudio, Salvador
    Corral, Gema
    Zeaiter, Ali
    Montilla, Lola
    Ribrag, Vincent
    CANCER MEDICINE, 2023, 12 (04): : 3999 - 4009
  • [30] Phase I Trial of Ibrutinib, Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
    Ailawadhi, Sikander
    Paulus, Aneel
    Alegria, Victoria R.
    Laplant, Betsy
    Moustafa, Muhamad Alhaj
    Chapin, Dustin
    Jackson, Keisha
    Jani, Prachi
    Ahmed, Salman
    Edwards, Brett
    Manna, Alak
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    BLOOD, 2019, 134
12345